D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Psychology D-index 97 Citations 29,964 403 World Ranking 475 National Ranking 307
Medicine D-index 97 Citations 31,799 415 World Ranking 5650 National Ranking 3126

Research.com Recognitions

Awards & Achievements

1980 - Fellow of the American Psychological Association (APA)

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Pharmacology
  • Psychiatry

His main research concerns Anesthesia, Pharmacology, Psychiatry, Drug and Caffeine. His Anesthesia study incorporates themes from Placebo, Benzodiazepine and Nicotine. His Placebo research is multidisciplinary, incorporating perspectives in Oral administration, Psychopharmacology and Mood.

His work in the fields of Sedative, Self-administration and Secobarbital overlaps with other areas such as Breaking point. His Drug study combines topics from a wide range of disciplines, such as Euphoriant, Energy and Environmental health. His Caffeine research is multidisciplinary, incorporating elements of Craving, Drug tolerance, Physiology and Physical dependence.

His most cited work include:

  • Caffeinated energy drinks--a growing problem. (695 citations)
  • Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. (617 citations)
  • Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. (430 citations)

What are the main themes of his work throughout his whole career to date?

Roland R. Griffiths mainly focuses on Anesthesia, Pharmacology, Placebo, Psychiatry and Drug. The study of Anesthesia is intertwined with the study of Benzodiazepine in a number of ways. His research integrates issues of Antagonist, Drug discrimination, Lorazepam and Caffeine in his study of Pharmacology.

His Caffeine research incorporates themes from Reinforcement and Physiology. As part of the same scientific family, he usually focuses on Placebo, concentrating on Audiology and intersecting with Developmental psychology. Roland R. Griffiths has researched Psilocybin in several fields, including Psychotherapist and Clinical psychology.

He most often published in these fields:

  • Anesthesia (33.65%)
  • Pharmacology (29.36%)
  • Placebo (20.76%)

What were the highlights of his more recent work (between 2010-2021)?

  • Psilocybin (12.41%)
  • Psychiatry (18.62%)
  • Hallucinogen (6.68%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Psilocybin, Psychiatry, Hallucinogen, Clinical psychology and Caffeine. His Psilocybin research includes elements of Psychotherapist, Distress and Social psychology, Mood. His Hallucinogen study is concerned with the field of Pharmacology as a whole.

Roland R. Griffiths is interested in Drug, which is a field of Pharmacology. While the research belongs to areas of Clinical psychology, he spends his time largely on the problem of Psychedelic experience, intersecting his research to questions surrounding Psychedelic drug. His studies deal with areas such as Anesthesia and High doses as well as Triazolam.

Between 2010 and 2021, his most popular works were:

  • Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. (430 citations)
  • Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness (374 citations)
  • Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (341 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Psychiatry
  • Pharmacology

Psilocybin, Hallucinogen, Psychedelic therapy, Psychiatry and Clinical psychology are his primary areas of study. His biological study spans a wide range of topics, including Psychotherapist, Internal medicine, Addiction and Anxiety. His studies in Hallucinogen integrate themes in fields like Anesthesia, Salvinorin A and Crossover study.

His work on Migraine as part of general Anesthesia research is frequently linked to Mint family, bridging the gap between disciplines. His Psychiatry research incorporates elements of Distress and MEDLINE. His research investigates the connection with Caffeine and areas like Mean age which intersect with concerns in Substance abuse.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.

R. R. Griffiths;W. A. Richards;U. McCann;R. Jesse.
Psychopharmacology (2006)

1389 Citations

Caffeinated energy drinks--a growing problem.

Chad J. Reissig;Eric C. Strain;Roland R. Griffiths.
Drug and Alcohol Dependence (2009)

1373 Citations

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.

Roland R Griffiths;Matthew W Johnson;Michael A Carducci;Annie Umbricht.
Journal of Psychopharmacology (2016)

1096 Citations

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

Roland R. Griffiths;William A. Richards;Matthew W. Johnson;Una D. McCann.
Journal of Psychopharmacology (2008)

832 Citations

Human hallucinogen research: guidelines for safety.

Matthew W. Johnson;William A. Richards;Roland R. Griffiths.
Journal of Psychopharmacology (2008)

752 Citations

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

Katherine A MacLean;Matthew W Johnson;Roland R Griffiths.
Journal of Psychopharmacology (2011)

721 Citations

A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features.

Laura M. Juliano;Roland R. Griffiths.
Psychopharmacology (2004)

676 Citations

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Roland R. Griffiths;Matthew W. Johnson;William A. Richards;Brian D. Richards.
Psychopharmacology (2011)

674 Citations

Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction

Matthew W Johnson;Albert Garcia-Romeu;Mary P Cosimano;Roland R Griffiths.
Journal of Psychopharmacology (2014)

643 Citations

Withdrawal syndrome after the double-blind cessation of caffeine consumption.

Kenneth Silverman;Suzette M. Evans;Suzette M. Evans;Eric C. Strain;Roland R. Griffiths.
The New England Journal of Medicine (1992)

523 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Roland R. Griffiths

Craig R. Rush

Craig R. Rush

University of Kentucky

Publications: 97

Robin L. Carhart-Harris

Robin L. Carhart-Harris

Imperial College London

Publications: 93

Warren K. Bickel

Warren K. Bickel

Virginia Tech

Publications: 84

Jack E. Henningfield

Jack E. Henningfield

Johns Hopkins University School of Medicine

Publications: 82

Stephen T. Higgins

Stephen T. Higgins

University of Vermont

Publications: 81

Maxine L. Stitzer

Maxine L. Stitzer

Johns Hopkins University School of Medicine

Publications: 76

David J. Nutt

David J. Nutt

Imperial College London

Publications: 71

Harriet de Wit

Harriet de Wit

University of Chicago

Publications: 66

Edward M. Sellers

Edward M. Sellers

University of Toronto

Publications: 60

John R. Hughes

John R. Hughes

University of Vermont

Publications: 56

George E. Bigelow

George E. Bigelow

Johns Hopkins University School of Medicine

Publications: 56

Richard W. Foltin

Richard W. Foltin

Columbia University

Publications: 44

Kenneth A. Perkins

Kenneth A. Perkins

University of Pittsburgh

Publications: 43

Thomas Roth

Thomas Roth

Henry Ford Hospital

Publications: 41

Jed E. Rose

Jed E. Rose

Duke University

Publications: 37

Steven R. Goldberg

Steven R. Goldberg

National Institute on Drug Abuse

Publications: 37

Trending Scientists

Aaron Cohen

Aaron Cohen

University of Haifa

Werner Schiehlen

Werner Schiehlen

University of Stuttgart

Mario di Bernardo

Mario di Bernardo

University of Naples Federico II

Yuliang Zhao

Yuliang Zhao

Center for Excellence in Education

Gustavo Caetano-Anollés

Gustavo Caetano-Anollés

University of Illinois at Urbana-Champaign

Gerhard Zotz

Gerhard Zotz

Smithsonian Tropical Research Institute

David W. Hird

David W. Hird

University of California, Davis

Vincent Corbel

Vincent Corbel

Institut de Recherche pour le Développement

Jian-Bo Zhou

Jian-Bo Zhou

Jilin University

L. Y. Chan

L. Y. Chan

Hong Kong Polytechnic University

Justin S. Rhodes

Justin S. Rhodes

University of Illinois at Urbana-Champaign

Peter Schirmacher

Peter Schirmacher

University Hospital Heidelberg

Robin Christensen

Robin Christensen

University of Southern Denmark

Thomas L. Diepgen

Thomas L. Diepgen

Heidelberg University

James W. Buehler

James W. Buehler

Drexel University

Something went wrong. Please try again later.